FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/12/048635 [Registered on: 30/12/2022] Trial Registered Prospectively
Last Modified On: 28/12/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical study to evaluate the effect of local ayurvedic application in umbilical cord care. 
Scientific Title of Study   Randomized controlled clinical trial to compare erandmool-amlak churna with neosporin powder in umbilical cord care. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nikita Sanjay Gadakh 
Designation  PG Scholar 
Affiliation  Tilak Ayurveda Mahavidyalaya 
Address  Department of Kaumarbhritya,Tilak Ayurved Mahavidyalaya,Pune 11

Pune
MAHARASHTRA
411011
India 
Phone  9960615313  
Fax    
Email  nikita3101995@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vikas Jaybhay 
Designation  HOD  
Affiliation  Tilak Ayurveda Mahavidyalaya 
Address  Department of Kaumarbhritya, Tilak Ayurved Mahavidyalaya, Pune 11

Pune
MAHARASHTRA
411011
India 
Phone  8888587158  
Fax    
Email  vikasjaybhay110@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vikas Jaybhay  
Designation  HOD  
Affiliation  Tilak Ayurveda Mahavidyalaya 
Address  Department of Kaumarbhritya, Tilak Ayurved Mahavidyalaya, Pune 11

Pune
MAHARASHTRA
411011
India 
Phone  8888587158  
Fax    
Email  vikasjaybhay110@gmail.com  
 
Source of Monetary or Material Support  
Tilak Ayurved Mahavidyalaya,Rasta peth,Pune 
 
Primary Sponsor  
Name  Tilak Ayurved Mahavidyalaya ,Pune 
Address  Rasta peth ,Pune-11 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nikita Sanjay Gadakh  Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurved Hospital  OPD no.20 and IPD of Department of Kaumarbhritya
Pune
MAHARASHTRA 
9960615313

nikita3101995@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee,Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurved Hospital,Pune  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Umbilical cord care in newborn to prevent umbilical sepsis 
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Erandmool-Amalak Churna, Reference: Arogya Raksha Kalpadrum adhyay 28 and Yogratnakar Abhav warg, Route: Topical, Dosage Form: Churna/ Powder, Dose: 30(mg), Frequency: tds, Bhaishajya Kal: Antarabhakta, Duration: 15 Days, anupAna/sahapAna: No, Additional Information: -Avoid water or oil application at umbilical region.
2Comparator Arm (Non Ayurveda)-Neosporin powderDose-30 mg Duration-15 days Frequency-TDS Route-topical application
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  28.00 Day(s)
Gender  Both 
Details  All Full term neonates
Willing of parents 
 
ExclusionCriteria 
Details  Neonates having pain or swelling or any inflammation sign at umbilical region.
Neonates admitted in NICU.
Non willing parents.
Neonates having congenital defects or who have been resuscitated. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Fall of umbilical cord without any inflammation and discharge.  baseline,3days,5days,7days,15days. 
 
Secondary Outcome  
Outcome  TimePoints 
Serous or any other discharge , inflammation after falling of umbilical cord.  15 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   02/01/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none yet. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Neonatal sepsis is the most important cause of morbidity and mortality.Though modern medicine is progressive but drugs used in umbilical sepsis in neonates has too much side effects so to establish the importance of Ayurvedic concepts and remedies related to Nabhinal paricharya,this study is selected. 
Close